RANZCO is a signatory in an open letter to Prime Minister Scott Morrison warning that Australia must significantly lift its commitment to the global effort to bring climate change under control, to save lives and protect health. Read more
Two Queensland practices join George & Matilda
George & Matilda Eyecare (G&M) has announced another two practices in Queensland have joined its community this month. Read more
Cylite continues to grow and launches new website
Australian HP-OCT manufacturer Cylite continues to grow with an ever-expanding workforce and the launch of its new website. Read more
People on the move – September 2021
Welcome to People on the move – September 2021, Insight’s monthly bulletin to keep the Australian ophthalmic sector updated on new appointments and personnel changes. Read more
Financial hardship taken into consideration as OBA fee rises 3% again
The Optometry Board of Australia (OBA) has increased its annual general registration fee for a third year in a row to align with indexation and will now cost $327. Read more
Ivantis to pay Glaukos US$60 million in MIGS patent settlement
MIGS device manufacturer Glaukos has reached an agreement with Ivantis over a patent infringement lawsuit regarding the latter’s Hydrus Microstent for glaucoma. Read more
Prof Robyn Guymer ‘thrilled’ by Phase 3 results of pegcetacoplan for dry AMD
Prominent Melbourne retinal disease researcher Professor Robyn Guymer is encouraged by the Phase 3 results of a trial she’s been involved in, investigating a new therapy she says is the only intervention shown to significantly slow the growth of lesions in dry AMD. Read more
NSW optometrist who saved child from brain haemorrhage awarded Dame Mary Perkins Medal
Specsavers co-founder Dame Mary Perkins made a special appearance to congratulate the first ever Australian and New Zealand recipients of a medal named in her honour recognising outstanding patient care. Read more
Complaints over compounded atropine eye drops in NSW
The Pharmacy Council of New South Wales has reported a rise in complaints over compounded atropine eye drops, with one patient lodging their grievance with Ahpra after becoming aware the formulation was not prepared under sterile conditions. Read more
Brisbane practices join National Optical Care
National Optical Care (NOC) has welcomed another new practice to its expanding portfolio. Read more